4 research outputs found
Nutrient Accumulation in Leaves and Soft Twigs of \u3ci\u3eMoringa oleifera\u3c/i\u3e Lam. at Different Growth Stages in Western Highland of Cameroon
Moringa oleifera belongs to the Moringaceae family and is considered to have its origin in the south of the Himalayan mountains. The species is being introduced into the highland zone of Cameroon. It is a tree which has many valuable properties and it is of great nutritional and scientific interest. The objective of this experiment was to evaluate nutrient composition in leaves and soft twigs of M. oleifera at different growth heights when grown in the Western Highland of Cameroon
Diversité Floristique Et Variation Altitudinale De La Structure Des Formations A Gnidia Glauca (Fresen) Gilg. Dans Les Forêts Communautaires De KilumIjim (Nord-Ouest Cameroun)
In order to find strategies for sustainable management of resources, a study was carried out on the analysis and management of stands of Gnidia glauca in the Kilum-Ijim region (North-West Cameroon). All individuals were identified and counted in 33 plots of 40mx40m established between 1963 and 2785 m altitude in these Gnidia glauca formations. The height and diameter of each individual were measured. A quadrat of 1m² was established around the mature trees to evaluate the regeneration. ANOVA was used to compare the average density of the species in various plots and the DUNCAN test at the 5% significance level (SPSS software version 17.0) was used to separate these means. It emerges from this study that the Thymelaeaceae (G. glauca) family is mainly represented. The Asteraceae, Rubiaceae, Poaceae and Fabaceae are the most diverse families in these formations. The distribution of individuals of G. glauca in diameter classes shows a decreasing pattern. The low density of G. glauca is observed at low altitudes (166.66 stems / hectare), and the high density is between 2350 and 2450 m (778.18 stems / ha). The average standing densities of G. glauca varies between 64.58 and 459.37 stems per hectare; these values indicate a good regeneration of this species in the site. G. glauca can therefore be rationally exploited in a sustainable way for the well-being of the surrounding human populations
Spatial and temporal dynamic of land-cover/land-use and carbon stocks in Eastern Cameroon: a case study of the teaching and research forest of the University of Dschang
A review of Cameroonian medicinal plants with potentials for the management of the COVID-19 pandemic
Since the outbreak in December 2019, in Wuhan (China) of COVID-19, approved drugs are still lacking and the world is seeking effective treatment. The purpose of this article is to review the medicinal plants with potential to be used as complementary therapies against COVID-19. Bibliographic information was searched in several databases (Google Scholar, PubMed, Scopus, ScienceDirect, PROTA, ResearchGate and GLOBEinMED), to retrieve relevant papers on (1) plants used to manage common symptoms of COVID-19, (2) plant secondary metabolites with confirmed inhibitory effects on COVID-19 and (3) plants exhibiting pharmacological activities of relevance for COVID-19 management. A total of 230 species was recorded as potential source of ingredients for the fight against the 2019 novel corona virus. Of these species, 30 contain confirmed antiCOVID-19 secondary metabolites, 90 are used traditionally to manage at least 3 common symptoms of COVID-19, 10 have immunostimulant activity, 52 have anti-inflamatory activity, 14 have antiviral properties and 78 species are documented as used to treat malaria. A PCA analysis showing cluster formatting among the recorded species indicates 4 groups of species and an array of possibility of using individual species or a combination of species for their complementary effects. The authors argue that Cameroonian medicinal plants can be of potential contribution to the fight against COVID-19. Further applied research is needed to provide more scientific evidence for their efficacy, to establish standard formulations and clinical studies as part of efforts to develop therapies for COVID-19